Evidence map›Paper›PMID 22167068›Full record

ArticleEndocrine-related cancer2012

Embryonic epithelial Pten deletion through Nkx2.1-cre leads to thyroid tumorigenesis in a strain-dependent manner.

Caterina Tiozzo, Soula Danopoulos, Maria Lavarreda-Pearce, Sheryl Baptista, Radka Varimezova, Denise Al Alam, David Warburton, Rehan Virender, Stijn De Langhe, Antonio Di Cristofano and 2 more

Erratum issuedOpen access · bronzeAbstract read
In one paragraph

Article in Endocrine-related cancer, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.4field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 10 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Mouse models of thyroid cancer: A 2015 update.Molecular and cellular endocrinology · 2016
    Review
  9. Genome-wide association mapping of acute lung injury in neonatal inbred mice.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2014
    Article
4 · The record

Corrections and comments

  • Erratum issued
    Virender, Rehan [corrected to Rehan, Virender]
5 · Who and what money

Authors and funding

12 authors at 6 institutions in 2 countries.

Caterina TiozzoDevelopmental Biology Program, Saban Research Institute of Childrens Hospital Los Angeles, Los Angeles, California 90027, USA.
Soula DanopoulosDevelopmental Biology Program, Saban Research Institute of Childrens Hospital Los Angeles, Los Angeles, California 90027, USA.
Maria Lavarreda-PearceDevelopmental Biology Program, Saban Research Institute of Childrens Hospital Los Angeles, Los Angeles, California 90027, USA.
Sheryl BaptistaDevelopmental Biology Program, Saban Research Institute of Childrens Hospital Los Angeles, Los Angeles, California 90027, USA.
Radka VarimezovaDevelopmental Biology Program, Saban Research Institute of Childrens Hospital Los Angeles, Los Angeles, California 90027, USA.
Denise Al AlamDevelopmental Biology Program, Saban Research Institute of Childrens Hospital Los Angeles, Los Angeles, California 90027, USA.
David WarburtonDevelopmental Biology Program, Saban Research Institute of Childrens Hospital Los Angeles, Los Angeles, California 90027, USA.
Rehan VirenderDepartment of Pediatrics, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, California 90502, USA.
Stijn De LangheDivision of Cell Biology, Department of Pediatrics, National Jewish Health, Denver, Colorado 80206, USA.
Antonio Di CristofanoDepartment of Developmental and Molecular Biology, Albert Einstein College of Medicine, Bronx, New York, USA.
Saverio Bellusci *Developmental Biology Program, Saban Research Institute of Childrens Hospital Los Angeles, Los Angeles, California 90027, USA.
Parviz Minoo *Developmental Biology Program, Saban Research Institute of Childrens Hospital Los Angeles, Los Angeles, California 90027, USA.
Children's Hospital of Los Angeles · USAlbert Einstein College of Medicine · USHarbor–UCLA Medical Center · USNassau University Medical Center · USNational Jewish Health · USUniversity of Southern California · US

Funding

TGF BETA SIGNALING IN LUNG MORPHOGENESIS, INJURY AND REPAIRP01HL060231 · NHLBI · CHILDREN'S HOSPITAL OF LOS ANGELES · PI HEISTERKAMP, NORA C · 1998 to 2009
$14.5M
Molecular analysis and therapeutic targeting of PI3K signaling in thyroid cancerR01CA128943 · NCI · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI DI CRISTOFANO, ANTONIO · 2009 to 2024
$5.8M
Growth Factors in Lung DevelopmentR01HL086322 · NHLBI · CHILDREN'S HOSPITAL OF LOS ANGELES · PI BELLUSCI, SAVERIO · 2008 to 2013
$2.2M
Lung regeneration and the stem cell nicheR01HL092967 · NHLBI · NATIONAL JEWISH HEALTH · PI DE LANGHE, STIJN PIET JOHAN · 2009 to 2013
$2.1M
NCI NIH HHS R01 CA128943NHLBI NIH HHS P01 HL060231NHLBI NIH HHS R01 HL086322NHLBI NIH HHS R01HL086322NHLBI NIH HHS R01 HL092967NHLBI NIH HHS R01HL092967
6 · The paper itself

Abstract

Even though the role of the tyrosine phosphatase Pten as a tumor suppressor gene has been well established in thyroid cancer, its role during thyroid development is still elusive. We therefore targeted Pten deletion in the thyroid epithelium by crossing Pten(flox/flox) with a newly developed Nkx2.1-cre driver line in the BALB/c and C57BL/6 genetic backgrounds. C57BL/6 homozygous Pten mutant mice died around 2 weeks of age due to tracheal and esophageal compression by a hyperplasic thyroid. By contrast, BALB/c homozygous Pten mutant mice survived up to 2 years, but with a slightly increased thyroid volume. Characterization of the thyroid glands from C57BL/6 homozygous Pten mutant mice at postnatal day 14 (PN14) showed abnormally enlarged tissue with areas of cellular hyperplasia, disruption of the normal architecture, and follicular degeneration. In addition, differing degrees of hypothyroidism, thyroxine (T(4)) decrease, and thyroid-stimulating hormone elevation between the strains in the mutants and the heterozygous mutant were detected at PN14. Finally, C57BL/6 heterozygous Pten mutant mice developed thyroid tumors after 2 years of age. Our results indicate that Pten has a pivotal role in thyroid development and its deletion results in thyroid tumor formation, with the timing and severity of the tumor depending on the particular genetic background.

Indexed as

AnimalsCell ProliferationCell Transformation, NeoplasticFemaleHistocytochemistryMaleMiceMice, Inbred BALB CMice, Inbred C57BLMice, KnockoutMice, TransgenicNuclear ProteinsPTEN PhosphohydrolaseReal-Time Polymerase Chain ReactionRNAThyroid GlandNkx2-1 protein, mouseNuclear ProteinsPTEN PhosphohydrolasePten protein, mouseRNAThyroid Nuclear Factor 1Transcription Factors

Identifiers

PMID22167068
PMCPMC4217534
OpenAlexW2131756825

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.